Clinical trial
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients…
NCT00006131 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00006131 |
|---|---|
| Title | Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | University of Texas |
| Status | Completed |
| Study type | Interventional |
| Conditions | Herpes Zoster, Immunologic Deficiency Syndromes |
| Intervention type | Drug |
| Interventions | Valacyclovir |
| Enrollment | 66 |
| Start date | Jan 1, 1997 |
| First posted | Aug 4, 2000 |
| Last update posted | May 24, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: